During the past decade, Universitätsklinikum Aachen, Frauenklinik - Senologie conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsklinikum Aachen, Frauenklinik - Senologie" #1 collaborator was "Genomic Health®, Inc." with 2 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Novartis" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Aachen, Frauenklinik - Senologie" are "Breast Cancer Female" (2 trials). Many other conditions were trialed in "Universitätsklinikum Aachen, Frauenklinik - Senologie" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Aachen, Frauenklinik - Senologie" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Abemaciclib 50 MG; 150mg 1-0-1 per os" (1 trials) and "Ribociclib 200Mg Oral Tablet" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Aachen, Frauenklinik - Senologie" are 2 trials for "Female" genders.

Currently, there are NaN active trials in "Universitätsklinikum Aachen, Frauenklinik - Senologie". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Universitätsklinikum Aachen, Frauenklinik - Senologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Aachen, Frauenklinik - Senologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".